You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacokinetics of 14C-OSI-906

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Lincoln (TAK-906 Oral Capsule, [14C]-TAK-906 Intravenous Infusion, [14C]-TAK-906 Oral Solution)

Completed
Has Results
  • Healthy Volunteers
  • TAK-906 Oral Capsule
  • +2 more
  • Lincoln, Nebraska
    Celerion
Dec 15, 2021

Healthy Volunteers Trial in Groningen (DC-806, [14C]-DC-806)

Recruiting
  • Healthy Volunteers
  • Groningen, Netherlands
    ICON Phase 1 Clinic
Sep 13, 2023

Pharmacokinetics Trial in Suzhou ([14C] ZSP1273)

Active, not recruiting
  • Pharmacokinetics
  • [14C] ZSP1273
  • Suzhou, China
    The First affiliated hospital of Suzhou university
May 15, 2023

Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)

Completed
  • Healthy Subjects
  • Pharmacokinetics of 14C-labeled of LXI-15028
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 22, 2023

Healthy Volunteers Trial in Suzhou ([14C]XZP-3621)

Not yet recruiting
  • Healthy Volunteers
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou Universiy
Apr 19, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • OMS906 Study Drug - 3 mg/kg
  • +2 more
  • Aachen, Germany
  • +4 more
Jul 25, 2023

Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)

Completed
  • Peripheral Analgesic and Anti-itch
  • Suzhou, Jiangsu, China
    f the First Affiliated Hospital of soochow University
Apr 19, 2023

Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)

Not yet recruiting
  • Healthy
  • BI 1810631 (C-14) formulation 1
  • +2 more
  • (no location specified)
May 25, 2023

Healthy Trial (BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550)

Not yet recruiting
  • Healthy
  • BI 1015550
  • BI 1015550 mixed with [C-14]-BI 1015550
  • (no location specified)
Feb 6, 2023

Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

Completed
  • Healthy Male Subjects
  • [14C] TS-142
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Healthy Male Subjects Trial in Tokyo (TAS-205, [14C]TAS-205)

Completed
  • Healthy Male Subjects
  • TAS-205, [14C]TAS-205
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Solid Tumors Trial in Budapest ([14C] Subasumstat, Subasumstat)

Not yet recruiting
  • Solid Tumors
  • Budapest, Hungary
  • +1 more
Jul 28, 2023

Healthy Trial in Groningen (BI 1291583 mixed with [C-14] BI 1291583)

Not yet recruiting
  • Healthy
  • BI 1291583 mixed with [C-14] BI 1291583
  • (no location specified)
Apr 17, 2023

Healthy Male Volunteers Trial in Madison ([14C]-BMS-986196)

Not yet recruiting
  • Healthy Male Volunteers
  • Madison, Wisconsin
  • +1 more
Aug 1, 2023

Healthy Trial in Madison (Radio-labeled rodatristat ethyl 600 mg)

Completed
  • Healthy
  • Radio-labeled rodatristat ethyl 600 mg
  • Madison, Wisconsin
    Covance Clinical Research Unit
Jul 12, 2022

Healthy Trial in Groningen (BI 764198 (C-14) (approach 1), BI 764198 (C-14) (approach 2))

Recruiting
  • Healthy
  • BI 764198 (C-14) (approach 1)
  • BI 764198 (C-14) (approach 2)
  • Groningen, Netherlands
    ICON
May 8, 2023

Healthy Trial in Groningen (BI 456906 (C-14))

Active, not recruiting
  • Healthy
  • BI 456906 (C-14)
  • Groningen, Netherlands
    ICON
Aug 9, 2022

HIV Trial in London (GSK3640254 Oral tablet, [14C]-GSK3640254 intravenous infusion, [14C]-GSK3640254 powder)

Completed
Has Results
  • HIV Infections
  • GSK3640254 Oral tablet
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
Nov 19, 2021

Healthy Volunteers Trial in Leeds (INCB086550)

Completed
  • Healthy Volunteers
  • Leeds, United Kingdom
    Covance Leeds Cru
Jun 16, 2022

Healthy Trial ([¹4C] BI 685509 formulation 1, [¹4C] BI 685509 formulation 2, BI 685509 formulation 3)

Not yet recruiting
  • Healthy
  • [¹⁴C] BI 685509 formulation 1
  • +2 more
  • (no location specified)
Aug 23, 2022

Healthy Volunteers Trial in Baltimore ([14C] BIIB122 ([14C] DNL151))

Completed
  • Healthy Volunteers
  • [14C] BIIB122 ([14C] DNL151)
  • Baltimore, Maryland
    Pharmaron CPC
Nov 30, 2021

Disorders of Sphingolipid Metabolism (Healthy Volunteers) Trial in Nottingham (venglustat)

Completed
  • Disorders of Sphingolipid Metabolism (Healthy Volunteers)
  • Nottingham, Nottinghamshire, United Kingdom
    Investigational Site Number :8260001
Mar 8, 2022

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Healthy Trial (BI 690517 (C-14), BI 690517)

Not yet recruiting
  • Healthy
  • BI 690517 (C-14)
  • BI 690517
  • (no location specified)
Aug 24, 2022

Environmental Exposure Trial in Corvallis ([14C]-benzo[a]pyrene, Brussels sprouts before 50 ng dose, DIM supplement before 50 ng

Active, not recruiting
  • Environmental Exposure
  • Corvallis, Oregon
    Oregon State University
Apr 20, 2022